# Drug Interaction Study With Rosuvastatin

> **NCT02101125** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 26 (actual)

## Conditions studied

- Immunosuppression For Disease

## Interventions

- **DRUG:** BMS-986020
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT02101125
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101125, "Drug Interaction Study With Rosuvastatin". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02101125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*